Cervical cancer is the fourth most common cancer among women. Infection by high-risk
human papillomavirus (HPV) is the main aetiology for the development of cervical cancer …

This review gives an overview of current screening practices for cervical cancer. In the
introduction, we will cover approaches of population screening focusing on high-risk Human …

The current practice of determining histologic grade with a single molecular biomarker can
facilitate differential diagnosis but cannot predict the risk of lesion progression. Cancer is …

Aims To investigate novel biomarker for diagnosis of cervical cancer, we analyzed the
datasets in Gene Expression Omnibus (GEO) and confirmed the candidate biomarker in …

Introduction Biomarkers yield important information for early diagnosis of cervical cancer.
However, they are rarely applied for prognosis of cervical cancer in Tanzania, where visual …

Cervical cancer is the fourth most common type of cancer in women worldwide. It is widely
accepted that the main cause of cervical cancer, especially in underdeveloped countries like …

Testin is a protein expressed in normal human tissues, being responsible, with other
cytoskeleton proteins, for the proper functioning of cell–cell junction areas and focal …

Background: Cervical cancer is considered the third leading cause of death among women
worldwide, and human papillomavirus was identified as a major causative agent for …

Introduction: Cervical cancer is the most common cancer among females. P16 is the
surrogate marker for cervical carcinoma. This study aimed to evaluate the association of P16 …

Introduction Tissue expression of P16ink4A is correlated with cervical lesions. In this study
we determined the association between serum P16ink4A concentrations and cervical …